Data as of Jul 25
| -0.21 / -0.62%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 36.70, with a high estimate of 42.29 and a low estimate of 29.33. The median estimate represents a +9.20% increase from the last price of 33.61.
The current consensus among 32 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.